ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China · Delayed Price · Currency is CNY 10.01
+0.01 (0.10%)
Jun 10, 2026, 3:00 PM CST
SHA:600479 Revenue
ZhuZhou QianJin Pharmaceutical Co.,Ltd had revenue of 970.27M CNY in the quarter ending March 31, 2026, a decrease of -3.46%. This brings the company's revenue in the last twelve months to 3.59B, down -1.10% year-over-year. In the year 2025, ZhuZhou QianJin Pharmaceutical Co.,Ltd had annual revenue of 3.63B, down -0.03%.
Revenue (ttm)
3.59B
Revenue Growth
-1.10%
P/S Ratio
1.37
Revenue / Employee
712.97K
Employees
5,041
Market Cap
4.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.63B | -961.39K | -0.03% |
| Dec 31, 2024 | 3.63B | -168.68M | -4.44% |
| Dec 31, 2023 | 3.80B | -227.79M | -5.66% |
| Dec 31, 2022 | 4.03B | 362.43M | 9.89% |
| Dec 31, 2021 | 3.66B | 36.88M | 1.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HPGC Renmintongtai Pharmaceutical | 10.54B |
| Jiangsu Lianhuan Pharmaceutical | 2.89B |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.68B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.04B |
| Jiangsu Jibeier Pharmaceutical | 990.68M |
| ChengDu ShengNuo Biotec | 801.40M |
| Chongqing Pharscin Pharmaceutical | 800.05M |
| Hainan Haiyao | 792.76M |